Iron Supplementation and Anemia After Sleeve Gastrectomy
Recruiting · NCT07397572 · Observational (researchers observe without assigning treatment) · Lead sponsor: Cairo University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this observational study is to learn if taking extra iron pills after weight loss surgery helps prevent low iron and anemia compared to just taking a standard multivitamin. The main question it aims to answer is: Does a specific iron supplementation plan lower the number of patients who develop iron deficiency anemia in the 6 months after sleeve gastrectomy surgery? Researchers will compare two groups of patients from different hospital units to see if the extra iron works: Patients from one unit who take a prophylactic iron supplement (Ferrodep, 60 mg per day) in addition to their standard multivitamin. Patients from another unit who take only a standard multivitamin (Centrum Silver). Participants in this study will: * Have their blood tested for iron and anemia levels before surgery, and again at 3 and 6 months after surgery, as part of their regular post-operative care. * Be asked about their health and quality of life during follow-up clinic visits. * Have their medical information from their hospital records reviewed by the study team to track their progress.
Who can take part
Inclusion criteria
- Adults aged 18 to 65 years scheduled to undergo primary laparoscopic sleeve gastrectomy (LSG).
- Capable of understanding and providing written informed consent for participation.
- Able and willing to commit to the 6-month post-operative follow-up schedule at the bariatric clinic.
Exclusion criteria
- Prior history of major gastrointestinal surgery (e.g., bowel resection, gastrectomy) that could independently affect iron absorption.
- Pre-existing malabsorptive conditions (e.g., inflammatory bowel disease, celiac disease).
- Diagnosis of other known forms of anemia (e.g., thalassemia, vitamin B12/folate deficiency, anemia of chronic disease) that would confound the diagnosis of iron deficiency anemia (IDA).
- Any condition that, in the investigator's judgment, would interfere with full participation in the study or pose a significant risk.
Where it is running
1 location listed.
- Faculty of Medicine Cairo University - Cairo, Al-Manial Cairo, Egypt